v3.25.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
OPERATING EXPENSES-    
RESEARCH AND DEVELOPMENT EXPENSES $ 802,102 $ 1,486,388
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES 1,965,133 2,011,246
Total operating expenses 2,767,235 3,497,634
OPERATING LOSS (2,767,235) (3,497,634)
OTHER INCOME (EXPENSE), NET    
Interest income 13,824 51,010
Interest expense (1,183,799) 0
Loss on debt extinguishment (728,298) 0
Total other (expense) income, net (1,898,273) 51,010
LOSS BEFORE INCOME TAXES (4,665,508) (3,446,624)
Income tax expense 0 0
NET LOSS (4,665,508) (3,446,624)
Deemed dividends on Series C and D Preferred Stock (32,552) (63,629)
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS $ (4,698,060) $ (3,510,253)
Basic and diluted loss per share $ (0.04) $ (0.04)
Weighted average shares of common stock outstanding- basic and diluted 108,468,489 81,094,007

Source